专题：Pharmaceutical Economics and Policy

This cluster of papers explores the economics of pharmaceutical research and development, focusing on topics such as drug development costs, generic drugs, pharmaceutical innovation, medicine prices, patent expiry, healthcare policies, market size, availability of medicines, and generic substitution.
最新文献
近5年高被引文献
Indian Journal of Pharmaceutical Education and Research

paratext Full Text OpenAlex 358 FWCI0

World Health Organization model list of essential medicines for children 8th list, 2021

article Full Text OpenAlex 347 FWCI115.7873

Vaccines safety case studies

book-chapter Full Text OpenAlex 332 FWCI95.4596

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

article Full Text OpenAlex 299 FWCI73.5534

Drug repurposing: a systematic review on root causes, barriers and facilitators

review Full Text OpenAlex 267 FWCI29.3246

Navigating financial toxicity in patients with cancer: A multidisciplinary management approach

article Full Text OpenAlex 259 FWCI49.6652

Improving data on pharmaceutical expenditure in hospitals and other health care settings

report Full Text OpenAlex 254 FWCI0

Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

article Full Text OpenAlex 232 FWCI46.9482

Costs of Drug Development and Research and Development Intensity in the US, 2000-2018

article Full Text OpenAlex 215 FWCI143.7942

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

article Full Text OpenAlex 212 FWCI43.947